Coherus BioSciences Inc banner

Coherus BioSciences Inc
NASDAQ:CHRS

Watchlist Manager
Coherus BioSciences Inc Logo
Coherus BioSciences Inc
NASDAQ:CHRS
Watchlist
Price: 1.63 USD -3.55% Market Closed
Market Cap: $197m

Cash Flow Statement

Cash Flow Statement
Coherus BioSciences Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Operating Cash Flow
Net Income
(54)
(70)
(86)
(73)
(87)
(103)
(137)
(200)
(224)
(249)
(260)
(104)
(128)
(137)
(122)
(265)
(238)
(208)
(196)
(196)
(209)
(185)
(118)
(12)
90
145
181
162
132
(76)
(165)
(232)
(287)
(210)
(231)
(279)
(292)
(271)
(264)
(217)
0
20
50
79
29
(131)
180
155
168
Depreciation & Amortization
0
0
0
1
1
1
1
2
2
2
3
3
3
3
3
3
3
3
4
4
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
4
4
Stock-Based Compensation
2
5
6
8
11
10
13
15
17
20
21
25
27
30
33
33
36
37
37
37
35
36
35
35
34
34
35
36
38
45
48
50
51
47
50
50
51
50
46
44
43
38
35
32
28
26
24
21
0
Other Non-Cash Items
27
42
43
32
34
26
22
23
23
21
28
30
32
36
30
32
40
40
40
44
37
38
42
39
49
49
56
59
51
207
196
202
203
95
106
127
126
83
77
49
96
(59)
(71)
(75)
(110)
48
(270)
(282)
(305)
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
4
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
7
0
0
0
8
0
0
0
8
0
0
0
15
0
0
0
17
0
0
0
19
0
0
0
35
0
0
0
38
0
0
0
25
0
0
0
10
Change in Working Capital
41
65
84
55
28
5
21
29
91
74
71
(88)
(159)
(151)
(189)
(28)
(5)
3
12
7
10
(39)
(61)
(66)
(114)
(99)
(94)
(85)
(32)
8
48
74
43
19
(21)
(45)
(79)
(72)
(62)
(98)
(37)
(39)
42
8
56
78
(20)
32
(6)
Cash from Operating Activities
15
N/A
37
+142%
41
+10%
14
-65%
(24)
N/A
(72)
-200%
(92)
-29%
(147)
-59%
(108)
+26%
(151)
-40%
(158)
-4%
(160)
-1%
(253)
-58%
(250)
+1%
(278)
-11%
(257)
+7%
(200)
+22%
(161)
+20%
(141)
+13%
(142)
-1%
(159)
-12%
(183)
-15%
(135)
+26%
(37)
+73%
28
N/A
99
+248%
146
+48%
139
-5%
154
+11%
142
-8%
82
-43%
48
-41%
(37)
N/A
(93)
-148%
(143)
-54%
(194)
-36%
(241)
-25%
(256)
-6%
(245)
+4%
(262)
-7%
(175)
+33%
(153)
+13%
(54)
+64%
(62)
-14%
(20)
+67%
1
N/A
(106)
N/A
(90)
+15%
(139)
-54%
Investing Cash Flow
Capital Expenditures
(0)
(1)
(2)
(3)
(3)
(4)
(4)
(5)
(6)
(7)
(6)
(4)
(7)
(6)
(7)
(8)
(5)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(6)
(7)
(7)
(6)
(4)
(2)
(1)
(2)
(2)
(3)
(2)
(2)
(1)
(0)
(0)
0
0
0
0
0
0
0
0
Other Items
0
2
2
2
2
0
0
(1)
(1)
0
0
0
0
(50)
(45)
(14)
0
37
15
(2)
(0)
(2)
23
11
(11)
4
(242)
(224)
(7)
(293)
(32)
(34)
(137)
113
89
73
(165)
(112)
(71)
(20)
145
330
316
266
230
10
445
377
375
Cash from Investing Activities
(0)
N/A
2
N/A
1
-68%
(0)
N/A
(1)
-150%
(4)
-680%
(4)
+8%
(6)
-67%
(7)
-15%
(8)
-12%
(7)
+9%
(4)
+39%
(7)
-51%
(56)
-762%
(52)
+8%
(22)
+57%
(4)
+80%
34
N/A
13
-61%
(3)
N/A
(1)
+54%
(3)
-167%
22
N/A
9
-59%
(13)
N/A
1
N/A
(247)
N/A
(231)
+7%
(14)
+94%
(298)
-1 972%
(35)
+88%
(36)
-1%
(138)
-287%
112
N/A
87
-22%
71
-19%
(167)
N/A
(114)
+32%
(72)
+37%
(21)
+71%
145
N/A
330
+128%
316
-4%
266
-16%
230
-13%
10
-96%
445
+4 319%
377
-15%
375
-1%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
55
55
55
55
11
11
12
81
72
128
252
183
257
207
84
184
110
105
112
15
17
17
13
17
18
21
21
62
58
54
51
5
4
9
16
69
80
74
69
15
3
3
1
0
0
8
Net Issuance of Debt
10
0
65
0
0
0
0
0
0
100
99
99
99
(1)
0
0
0
0
0
0
0
73
73
73
73
0
205
204
204
0
(1)
(0)
(1)
(0)
(0)
49
50
50
50
0
0
0
(223)
(223)
(223)
0
(233)
(233)
(233)
Other
0
0
(1)
(3)
81
80
193
195
111
112
(0)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
(1)
0
0
0
0
(1)
(2)
(2)
(2)
(1)
(2)
(2)
(2)
(2)
(3)
(4)
(4)
(5)
(5)
(5)
(5)
(5)
(2)
33
33
34
34
(49)
(49)
(49)
Cash from Financing Activities
10
N/A
10
N/A
64
+540%
52
-18%
136
+161%
135
-1%
194
+43%
206
+6%
123
-40%
223
+82%
180
-19%
171
-5%
226
+33%
251
+11%
182
-28%
256
+41%
207
-19%
84
-60%
184
+120%
110
-40%
105
-4%
185
+76%
88
-52%
91
+3%
89
-2%
12
-87%
219
+1 758%
220
+0%
224
+2%
222
-1%
59
-74%
56
-5%
52
-7%
48
-8%
2
-97%
49
+3 180%
54
+10%
60
+10%
114
+89%
76
-33%
70
-8%
67
-4%
(176)
N/A
(187)
-6%
(187)
0%
(188)
-1%
(282)
-50%
(282)
+0%
(274)
+3%
Change in Cash
Effect of Foreign Exchange Rates
0
(0)
0
(0)
(1)
(1)
(1)
(1)
0
0
0
0
(0)
(1)
(0)
(0)
(0)
0
0
0
1
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
25
N/A
49
+96%
106
+116%
66
-37%
111
+68%
59
-47%
97
+65%
53
-46%
8
-85%
65
+718%
15
-77%
6
-59%
(33)
N/A
(55)
-65%
(148)
-170%
(24)
+84%
2
N/A
(43)
N/A
57
N/A
(34)
N/A
(55)
-59%
(1)
+99%
(24)
-4 720%
63
N/A
105
+66%
111
+6%
118
+6%
128
+8%
364
+184%
66
-82%
105
+59%
68
-35%
(124)
N/A
66
N/A
(54)
N/A
(74)
-36%
(354)
-379%
(310)
+12%
(203)
+35%
(207)
-2%
39
N/A
244
+519%
86
-65%
17
-80%
23
+33%
(178)
N/A
57
N/A
6
-90%
(37)
N/A
Free Cash Flow
Free Cash Flow
15
N/A
37
+145%
39
+7%
12
-70%
(27)
N/A
(76)
-183%
(96)
-27%
(152)
-59%
(114)
+25%
(158)
-39%
(164)
-4%
(165)
0%
(259)
-57%
(256)
+1%
(285)
-11%
(265)
+7%
(205)
+23%
(164)
+20%
(143)
+13%
(143)
N/A
(160)
-12%
(184)
-15%
(136)
+26%
(38)
+72%
27
N/A
96
+259%
141
+47%
132
-6%
147
+11%
137
-7%
78
-43%
46
-41%
(39)
N/A
(95)
-144%
(145)
-53%
(196)
-35%
(243)
-24%
(257)
-6%
(245)
+5%
(262)
-7%
(175)
+33%
(153)
+13%
(54)
+64%
(62)
-14%
(20)
+67%
1
N/A
(106)
N/A
(90)
+15%
(139)
-54%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett